Skip to main content

Featured

Toronto Lights Up the Waterfront: New Year’s Eve Celebrations Set to Dazzle the GTA

  Toronto is preparing for one of its most vibrant New Year’s Eve celebrations yet, with the city’s waterfront transforming into a massive outdoor festival to welcome 2026. Beginning at 10 p.m., the Harbourfront area will come alive with live music, DJ sets, roaming performers, and illuminated art installations stretching from Harbourfront Centre to Sherbourne Common. The night’s biggest draw will be a 10‑minute fireworks display launched over the inner harbour , offering sweeping views from along the lakeshore. The show is designed to be visible from multiple waterfront vantage points, giving thousands of residents and visitors a chance to ring in the new year under a bright skyline. Transit agencies across the region are stepping up to support the festivities. TTC, GO Transit, and UP Express will offer free rides from 7 p.m. on December 31 until 8 a.m. on January 1 , with extended service to help crowds travel safely throughout the night. Beyond downtown, communities across t...

article

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Comments